XML 68 R42.htm IDEA: XBRL DOCUMENT v3.21.4
Note 8 - Common Stock, Warrants and Preferred Stock: Schedule of Stockholders' Equity Note, Warrants or Rights (Tables)
12 Months Ended
Sep. 30, 2021
Tables/Schedules  
Schedule of Stockholders' Equity Note, Warrants or Rights

 

Shares

 

Exercise

Price ($)

Expiration Date

Series C Warrants: (Issued for Private Placement)

 

 

 

 

Outstanding and exercisable at September 30, 2019

2,880,867

 

0.45

October 31, 2022

Outstanding and exercisable at September 30, 2020

2,880,867

 

 

 

Outstanding and exercisable at September 30, 2021

2,880,867

 

 

 

Series D Warrants: (Issued for Private Placement)

 

 

 

 

Outstanding and exercisable at September 30, 2019

7,500,000

 

0.14

April 30, 2021

Outstanding and exercisable at September 30, 2020

7,500,000

 

 

 

Exercised

(3,500,000)

 

 

 

Expired

(4,000,000)

 

 

 

Outstanding and exercisable at September 30, 2021

-

 

 

 

Series D-2 Warrants: (Issued for Mineral Property Purchase)

 

 

 

 

Outstanding and exercisable at September 30, 2019

5,000,000

 

0.24

May 23, 2021

Outstanding and exercisable at September 30, 2020

5,000,000

 

 

 

Expired

(5,000,000)

 

 

 

Outstanding and exercisable at September 30, 2021

-

 

 

 

Series E Warrants: (Issued for Private Placement)

 

 

 

 

Outstanding and exercisable at September 30, 2019

7,500,000

 

0.14

October 29, 2021

Outstanding and exercisable at September 30, 2020

7,500,000

 

 

 

Exercised

(675,000)

 

 

 

Outstanding and exercisable at September 30, 2021

6,825,000

 

 

 

Series F Warrants: (Issued for Unsecured Senior Note)

 

 

 

 

Outstanding and exercisable at September 30, 2019

3,265,500

 

0.09

February 1, 2023

Exchanged for Series K warrants

(3,265,500)

 

 

 

Outstanding and exercisable at September 30, 2020

-

 

 

 

Outstanding and exercisable at September 30, 2021

-

 

 

 

Series G Warrants: (Issued for Mineral Property Purchase)

 

 

 

 

Outstanding and exercisable at September 30, 2019

5,000,000

 

0.24

December 18, 2021

Outstanding and exercisable at September 30, 2020

5,000,000

 

 

 

Outstanding and exercisable at September 30, 2021

5,000,000

 

 

 

Series H Warrants: (Issued for Private Placement)

 

 

 

 

Outstanding and exercisable at September 30, 2019

6,367,441

 

0.14

March 22, 2022

Outstanding and exercisable at September 30, 2020

6,367,441

 

 

 

Exercised

(375,000)

 

 

 

Outstanding and exercisable at September 30, 2021

5,992,441

 

 

 

Series I Warrants: (Issued for Unsecured Note Payable)

 

 

 

 

Outstanding and exercisable at September 30, 2019

3,543,600

 

0.07

November 7, 2020

Exercised

(3,543,600)

 

 

 

Outstanding and exercisable at September 30, 2020

-

 

 

 

Outstanding and exercisable at September 30, 2021

-

 

 

 

Series J Warrants: (Issued for Private Placement)

 

 

 

 

Warrants Issued October 15, 2019

3,750,000

 

0.12

October 15, 2024

Outstanding and exercisable at September 30, 2020

3,750,000

 

 

 

Outstanding and exercisable at September 30, 2021

3,750,000

 

 

 

Series K Warrants: (Issued for Extension of Unsecured Note Payable)

 

 

 

 

Warrants Issued January 20, 2020 in exchange for Series F warrants

4,000,000

 

0.08

January 20, 2023

Outstanding and exercisable at September 30, 2020

4,000,000

 

 

 

Outstanding and exercisable at September 30, 2021

4,000,000

 

 

 

Series L Warrants: (Issued for Private Placement)

 

 

 

 

Warrants Issued August 15, 2020

33,636,364

 

0.20

August 15, 2023

Outstanding and exercisable at September 30, 2020

33,636,364

 

 

 

Outstanding and exercisable at September 30, 2021

33,636,364

 

 

 

Series M Warrants: (Issued for Private Placement)

 

 

 

 

Warrants Issued June 25, 2021

12,131,647

 

0.30

May 21, 2023

Outstanding and exercisable at September 30, 2021

12,131,647

 

 

 

 

 

 

 

 

Warrants outstanding and weighted average exercise price at September 30, 2021

74,216,319

 

0.21